Pembrolizumab Plus Chemotherapy to Combat Breast Cancer

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：561 / 561
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab plus Chemotherapy for triple-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1114 - 1114
  • [2] Pembrolizumab plus chemotherapy in triple-negative breast cancer Reply
    Cortes, Javier
    Rugo, Hope S.
    Guo, Zifang
    Karantza, Vassiliki
    Schmid, Peter
    LANCET, 2021, 398 (10294): : 24 - 25
  • [3] Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
    Cortes, J.
    Rugo, H. S.
    Cescon, D. W.
    Im, S-A
    Yusof, M. M.
    Gallardo, C.
    Lipatov, O.
    Barrios, C. H.
    Perez-Garcia, J.
    Iwata, H.
    Masuda, N.
    Otero, M. Torregroza
    Gokmen, E.
    Loi, S.
    Guo, Z.
    Zhou, X.
    Karantza, V
    Pan, W.
    Schmid, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03): : 217 - 226
  • [4] Pembrolizumab plus Chemotherapy in Lung Cancer
    Sun, Ryan
    Rich, Michael W.
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11):
  • [5] Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer
    Eskander, Ramez N.
    Sill, Michael W.
    Beffa, Lindsey
    Moore, Richard G.
    Hope, Joanie M.
    Musa, Fernanda B.
    Mannel, Robert
    Shahin, Mark S.
    Cantuaria, Guilherme H.
    Girda, Eugenia
    Mathews, Cara
    Kavecansky, Juraj
    Leath, Charles A.
    Gien, Lilian T.
    Hinchcliff, Emily M.
    Lele, Shashikant B.
    Landrum, Lisa M.
    Backes, Floor
    O'Cearbhaill, Roisin E.
    Al Baghdadi, Tareq
    Hill, Emily K.
    Thaker, Premal H.
    John, Veena S.
    Welch, Stephen
    Fader, Amanda N.
    Powell, Matthew A.
    Aghajanian, Carol
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (07) : 406 - 407
  • [6] Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
    Eskander, Ramez N.
    Sill, Michael W.
    Beffa, Lindsey
    Moore, Richard G.
    Hope, Joanie M.
    Musa, Fernanda B.
    Mannel, Robert
    Shahin, Mark S.
    Cantuaria, Guilherme H.
    Girda, Eugenia
    Mathews, Cara
    Kavecansky, Juraj
    Leath III, Charles A.
    Gien, Lilian T.
    Hinchcliff, Emily M.
    Lele, Shashikant B.
    Landrum, Lisa M.
    Backes, Floor
    O'Cearbhaill, Roisin E.
    Al Baghdadi, Tareq
    Hill, Emily K.
    Thaker, Premal H.
    John, Veena S.
    Welch, Stephen
    Fader, Amanda N.
    Powell, Matthew A.
    Aghajanian, Carol
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (23): : 2159 - 2170
  • [7] Pembrolizumab plus chemotherapy for advanced gastric cancer
    Rha, Sun Young
    Bordia, Sonal
    LANCET ONCOLOGY, 2024, 25 (02): : e52 - e52
  • [8] KEYNOTE-355 Asian subset: Pembrolizumab plus chemotherapy vs placebo plus chemotherapy for triple-negative breast cancer
    Takano, Toshimi
    Cortes, Javier
    Cescon, David W.
    Im, Seock-Ah
    Yusof, Mastura Md
    Iwata, Hiroji
    Masuda, Norikazu
    Huang, Chiun-Sheng
    Chung, Chi-Feng
    Tsugawa, Koichiro
    Park, Yeon Hee
    Matsumoto, Koji
    Inoue, Kenichi
    Kwong, Ava
    Loi, Sherene
    Fu, Wei
    Pan, Wilbur
    Karantza, Valia
    Rugo, Hope S.
    Schmid, Peter
    ANNALS OF ONCOLOGY, 2022, 33 : S465 - S465
  • [9] KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer
    McArthur, Heather
    Cortes, Javier
    Dent, Rebecca
    Pusztai, Lajos
    Kuemmel, Sherko
    Bergh, Jonas
    Denkert, Carsten
    Park, Yeon Hee
    Hui, Rina
    Harbeck, Nadia
    Takahashi, Masato
    Untch, Michael
    Fasching, Peter A.
    Cardoso, Fatima
    Andersen, Jay
    Patt, Debra
    Danso, Michael
    Ferreira, Marta
    Mouret-Reynier, Marie-Ange
    Im, Seock-Ah
    Ahn, Jin-Hee
    Gion, Maria
    Baron-Hay, Sally
    Boileau, Jean-Francois
    Zhu, Yalin
    Pan, Wilbur
    Tryfonidis, Konstantinos
    Karantza, Vassiliki
    O'Shaughnessy, Joyce
    Schmid, Peter
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 338 - 338
  • [10] Chemotherapy plus Pembrolizumab for High-risk Endometrial Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2025, 85 (03)
12345